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Hallucinations and other unusual sensory experiences (USE) can occur in all modalities
in the general population. Yet, the existing literature is dominated by investigations
into auditory hallucinations (“voices”), while other modalities remain under-researched.
Furthermore, there is a paucity of measures which can systematically assess different
modalities, which limits our ability to detect individual and group differences across
modalities. The current study explored such differences using a new scale, the
Multi-Modality Unusual Sensory Experiences Questionnaire (MUSEQ). The MUSEQ
is a 43-item self-report measure which assesses USE in six modalities: auditory,
visual, olfactory, gustatory, bodily sensations, and sensed presence. Scale development
and validation involved a total of 1,300 participants, which included: 513 students
and community members for initial development, 32 individuals with schizophrenia
spectrum disorder or bipolar disorder for validation, 659 students for factor replication,
and 96 students for test-retest reliability. Confirmatory factor analyses showed that
a correlated-factors model and bifactor model yielded acceptable model fit, while a
unidimensional model fitted poorly. These findings were confirmed in the replication
sample. Results showed contributions from a general common factor, as well as
modality-specific factors. The latter accounted for less variance than the general factor,
but could still detect theoretically meaningful group differences. The MUSEQ showed
good reliability, construct validity, and could discriminate non-clinical and clinical groups.
The MUSEQ offers a reliable means of measuring hallucinations and other USE in six
different modalities.
Keywords: hallucination, voices, visions, sensed presence, perception, sensory modalities, self-report scale,
proneness
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INTRODUCTION
The assessment and classification of psychopathology and other
psychological constructs is historically categorical in nature.
Some mental experiences, however, can occur on a continuum
ranging from subthreshold levels in the general population to
acute symptoms in clinical groups, and this observation has led
to the exploration of symptom dimensions. In particular, the
psychosis continuum theory (Johns and Van Os, 2001) suggests
that the positive symptoms of psychosis (i.e., hallucinations and
delusions) can exist at attenuated levels in the general population
without being associated with distress or a loss of contact with
reality that might warrant a need for treatment (Preti et al., 2014;
Brett et al., 2015; Waters et al., 2017).
Although the psychosis continuummodel is debated (Kaymaz
and Van Os, 2010; Lawrie et al., 2010), there is overwhelming
evidence that people in the general population report a range
of hallucinations and other unusual sensory experiences (USE)
(see Nuevo et al., 2010; Pechey and Halligan, 2012; McGrath
et al., 2015). In this report, the term USE refers to a range of
phenomena such as hallucinations and misperceptions where
there is discrepancy between what is perceived and what
actually exists in the real world. It is sometimes difficult
to precisely distinguish hallucinations from other perceptual
experiences given that perception is subjective and complex
(Dror, 2005), and there is no clear-cut distinction between
categories of experiences. Nonetheless, hallucinations are often
defined as waking experiences which have the character of
veridical perceptions, but are elicited in the absence of a relevant
external stimulus. Misperceptions refer to experiences (images,
sounds, etc.) whose relationship to stimuli in the outside world is
distorted or changed in some way.
Studies of USE in the general population typically focus
on hallucinations. Epidemiological studies estimate a lifetime
prevalence of approximately 5–30% of (Linscott and Van Os,
2013; Kråkvik et al., 2015; McGrath et al., 2015; Peters et al.,
2016). For about 80% of individuals who experience psychotic-
like experiences (including hallucinations), these are transient
experiences that tend to remit over time (Linscott and Van
Os, 2013). In the remaining 20%, symptoms are persistent and
distressing, and approximately 7% may go on to develop a
psychotic disorder (Linscott and Van Os, 2013). Studies tend
to screen community participants for psychiatric disorders, but
it is possible that these experiences are related to prodromal
psychosis, an undiagnosed medical condition (e.g., disease of the
sensory organs), or other disorders (e.g., sleep disorders).
The auditory and visual modalities are the most commonly
investigated, although investigators often tend to focus
exclusively on one modality. The other sensory modalities
however require further attention. USE can occur in different
Abbreviations: Analyses: EFA, Exploratory Factor Analysis; CFA, Confirmatory
Factor Analysis; PCA, Principal Components Analysis. Modalities: A, Auditory;
V, Visual; O, Olfactory; G, Gustatory; BS, Bodily Sensations; SP, Sensed Presence.
Scales/Subscales: LSHS-M-II, Launay Slade Hallucination Scale-Modified-II;
CAPS, Cardiff Anomalous Perception Scale; D, Distress; I, Intrusiveness;
F, Frequency; UE, Unusual Experiences; CD, Cognitive Disorganization; IA,
Introvertive Anhedonia; IN, Impulsive Non-Conformity.
modalities (e.g., auditory, visual, olfactory, gustatory, and bodily
sensations), as shown in a broad variety of clinical conditions
(e.g., schizophrenia and other psychosis, neurodegenerative
diseases, eye disease, and temporal lobe epilepsy) (see
Lewandowski et al., 2009; Ford and Almeida, 2014; Larøi
et al., 2014; Stephane et al., 2014; Waters et al., 2014a). Different
modalities of USE have also been reported in the general
population (Tien, 1991; Ohayon, 2000; Peters et al., 2016).
Lifetime prevalence rates of auditory hallucinations range
between 2.5 and 15% (e.g., Beavan et al., 2011; Kråkvik et al.,
2015; McGrath et al., 2015). Similarly, visual experiences are
relatively common with lifetime estimates ranging between
3 and 15%, and these prevalence rates escalate rapidly in
association with increase age, visual loss, social isolation, and
sleep deprivation (Tien, 1991; Ohayon, 2000; McGrath et al.,
2015; Peters et al., 2016). Studies also suggest non-negligible
lifetime estimates of olfactory hallucinations in approximately 3–
9% of the population (Ohayon, 2000; García-Ptacek et al., 2013),
gustatory hallucinations in 1% (Tien, 1991; Ohayon, 2000), and
bodily/somatic hallucinations in 3–7% (Ohayon, 2000; Shevlin
et al., 2007; Peters et al., 2016). Peters et al. (2016) even suggest
that bodily and olfactory hallucinations may be more common
in the general community than in psychosis. Sensed presence
is another sensory domain which is underreported. Despite
limited research, existing evidence suggests that the lifetime
prevalence of sensed presence experiences may be as high as
30–60% in selected (e.g., bereaved) populations (Castelnovo
et al., 2015).
Given the existence of USE in multiple sensory domains,
comprehensive and sensitive assessment scales are required,
although currently lacking. The development of a comprehensive
and accurate measure of USE in different modalities is critical
to furthering our understanding of these phenomena, and of
their relation to other psychological constructs and mental
health outcomes. Until now, the presence and frequency of
hallucinations and other USE in the general population have
been assessed rather broadly. For example, scales such as the
Oxford-Liverpool Inventory of Feelings and Experiences (O-
LIFE; Mason et al., 1995, 2005) which targets the schizotypy
personality construct, assess unusual experiences via items
relating to daydreaming, magical thinking, and paranoia. This
limits the subscale’s utility in examining specific perceptual
changes.
The Launay Slade Hallucination Scale (LSHS; Launay and
Slade, 1981) and its revisions (e.g., Revised Hallucination Scale;
Morrison et al., 2000; LSHS-Modified; Larøi et al., 2004;
LSHS-Modified-II [LSHS-M-II]; Larøi and Van der Linden,
2005), are the most commonly used measures of hallucination
“proneness.” Recent versions of the LSHS (e.g., LSHS-M-II)
target hallucinations in various modalities (auditory, visual,
olfactory, tactile, and sensed presence) (Larøi and Van der
Linden, 2005; Kråkvik et al., 2015). However, these modalities are
not assessed in detail (i.e., one or two items per modality) and the
scale was developed without theoretical underpinnings except to
build on the notion of “proneness,” which does not have a clear
definition or meaning. If the focus of research is on particular
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aspects of hallucinations in the community, the development of
more internally consistent scale is required.
A more detailed focus on perceptual anomalies was achieved
with the Cardiff Anomalous Perception Scale (CAPS; Bell et al.,
2006). The CAPS assesses a range of perceptual anomalies
in different modalities, but these are grouped into different
phenomenological dimensions (e.g., changes in sensory intensity,
sensory experience from an unexplained source, and thought
echo) rather than by modality. Precise frequency labels are also
lacking, which limits the assessment of frequency and persistence
of symptoms which can signal a transition into a psychotic state
(Stefanis et al., 2002; Dominguez et al., 2011). In summary, no
measure is yet available to systematically explore the frequency
of hallucination and USE in different modalities. The first aim of
this study was therefore to create a scale that assesses USE in the
six most common sensory modalities.
Scale development and validation, however, is not a simple
task, particularly if different factors/modalities are thought
to be separable. The ability to accurately measure USE in
different modalities is dependent on the statistical separability
of these experiences. Principal components analyses and
exploratory methods were previously used to guide previous
scale development (e.g., in the creation of the CAPS). These
methods can be helpful for item reduction, although there
is no a priori expectation regarding how items may be
related.
One question to consider is whether USE are better explained
by a single general “proneness” or “hallucination” factor, or
whether the different modalities are sufficiently unique to
lead to individual differences. Previous findings have indicated
significant correlations between hallucinations in different
modalities within the same individuals (e.g., Launay and Slade,
1981; Morrison et al., 2000; Larøi and Van der Linden, 2005; Bell
et al., 2006; Lewandowski et al., 2009; Preti et al., 2014). However,
evidence from phenomenological and neurobiological studies
also indicated that USE can be differentiated at the modality level
(Weiss and Heckers, 1999; Larøi, 2006; Jardri et al., 2013; Waters
et al., 2014b), such that individuals may only ever experience
hallucinations in one modality. Since both approaches appear
valid, we put forward a third possiblity which incorporates both
views, and which proposes one large general factor as well as
unique variance from different modalities.
This hybrid approach has support from other domains of
psychology. For example, Lahey et al. (2012) proposed that high
correlations between dimensions of general psychopathology
(externalizing, internalizing, and thought disorder) may be
reflective of a general factor representing an individual’s
predisposition to developing psychopathology, but with
additional separate factors which act to shape this vulnerability
into a specific symptommanifestation. Statistical methods which
employ confirmatory factor analysis using a bifactor modeling
approach (e.g., Caspi et al., 2014; Laceulle et al., 2015; Waldman
et al., 2016) also support this model.
A bifactor modeling approach assessing for the presence of a
general factor and (typically correlated) domain-specific latent
factors has also been used successfully in psychosis research
by Reininghaus et al. (2013). Their findings demonstrated the
presence of a general psychosis factor as well as individual
symptom dimensions. This has been replicated in a general
population sample (Shevlin et al., 2016). Interpretations of what
the general factor represents include a general risk or common
etiology, associated distress or impairment, or a level of symptom
acuity (Lahey et al., 2012; Caspi et al., 2014; Waldman et al.,
2016).
This hierarchical structure is yet to be explored in relation
to different sensory modalities of USE, and to do so is
of great importance in furthering our understanding of the
commonalities and separability of these phenomena. It also
allows us to explore conceptual issues relating modality-specific
vs. generalized deficits. Indeed, the nature of hallucinations
in individuals with psychosis, in which the presence of
hallucinations in the auditory and visual modalities increases the
chance of additional hallucinations (e.g., tactile and olfactory)
(see Lim et al., 2016; Clark et al., 2017), suggests related but
potentially differentiable “vulnerability” mechanisms.
Notwithstanding the possibility of a general USE factor,
evidence exists of independent sensory contributions.
Examples include schizophrenia spectrum disorders, which
are characterized predominantly by auditory hallucinations in
contrast to other medical conditions and psychiatric disorders,
in which visual hallucinations are more common (Lewandowski
et al., 2009; Waters et al., 2014a). Another example includes
an overrepresentation of visual hallucinations in developing
countries compared to Western cultures (Luhrmann, 2011). Yet
another example is that of the role of childhood traumampacting
on the specific modality of USE, with tactile hallucinations being
linked to physical abuse and visual hallucinations with neglect
(Shevlin et al., 2007). Factors which serve to accentuate the
expression of one modality over another therefore appear to
include neurobiological mechanisms, culture, and psychosocial
factors.
Such findings indicate that USE should be characterized by
multiple sensory dimensions, and also indicate the importance
of assessing both a general factor and individual modalities.
Confirmatory approaches are preferred in scale development
where theoretical knowledge anticipates a relationship between
items (TenHolt et al., 2010). Exploratory approaches, by contrast,
do not allow for the testing of multidimensionality or higher-
order constructs which may result in an inappropriate solution
(McGartland Rubio et al., 2001). The second aim of this study
was therefore to perform a series of confirmatory factor analyses
to assess the factor structure of the new scale. Specifically, we
aimed to test alternative models of the factorial structure of USE
as a way of exploring their potential separability at the modality
level.
In summary, existing measures of USE have contributed to
a rich body of knowledge but are limited in their ability to
systematically assess different modalities. Approaches toward
scale development also need to be more systematic and
theoretically guided to validly measure USE in their respective
modalities. Specifically, the possibility of a model structure
comprising a general factor and modality-specific factors is yet
to be explored regarding USE. Therefore, the aims of the current
study were to:
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(1) Create a scale that separately assesses USE in six common
sensory modalities, and
(2) Evaluate the psychometric properties of this scale, while
testing alternative factor structure models to explore the
contribution of general and specific factors.
We report on the development and psychometric properties
of the resulting scale, called the Multi-Modality Unusual
Sensory Experiences Questionnaire (MUSEQ). The development
of the MUSEQ was theory-driven with a priori hypotheses
regarding the relationship between modalities. Specifically, it was
hypothesized that all items (and modalities) would be positively
related to each other, but still be separable into modality-specific
domains. Results regarding the factorial structure are checked in
a replication sample.
METHOD
Participants
Non-clinical
Six-hundred and sixteen participants took part in the initial
scale development study. Forty participants were excluded due
to incomplete questionnaires. Recruitment targeted students
(N = 298) and non-student general community volunteers
(N = 215) aged 17 and above. Students were recruited via
an undergraduate student pool at the University of Western
Australia and through research and social media websites (Call
for Participants, Psychological Research on the Net, Online
Psychology Research UK, The Inquisitive Mind, PsyResearch,
Social Psychology Network, Intervoice, U3A Online, Facebook,
Find Participants, and CrowdFlower). The community sample
was also obtained via these websites. To ensure endorsed USE
were not due to other psychiatric and neurological conditions,
exclusion criteria included a self-reported history of diagnosed
schizophrenia spectrum disorder or bipolar disorder (N = 31),
epilepsy (N = 10), neurodegenerative disease (N = 4), and
traumatic brain injury associated with loss of consciousness
(N = 18).
The final sample comprised 513 participants (386 female, 127
male), with a mean age of 27.75 years (SD = 13.28, range 17–76;
N = 489). Participants were drawn from Australia (48.7%),
United States of America/Canada (42.8%), United Kingdom
(5.3%), and other countries (3.2%), with most obtaining an
education level of high school or greater (High School 53.4%;
Tertiary Studies 37.0%; other 9.6%). Participants who were not
students (N = 215) predominantly worked full-time (50.2%),
followed by part-time work (20%), unemployment (14%),
retirement (8.4%), casual work (5.6%), and volunteering (1.9%).
Reported marital status was as follows: Single (69.4%), Married
(14.8%), De Facto (9.9%), Divorced (4.3%), and Widowed
(1.6%). Religious affiliations were: Atheism (44.8%), Christianity
(39.4%), Buddhism (2.9%), Islam (2.3%), Judaism (1.2%),
Hinduism (1.0%), other (6.2%), and undisclosed (2.1%).
Clinical
Thirty-two individuals (20 female, 12 male) with schizophrenia
spectrum disorder (N = 10) or bipolar disorder (N = 14)
completed the MUSEQ (age M = 34.17 years, SD = 13.09,
range 18–67) for validation purposes. Participants reported their
diagnosis was made by a medical or mental health practitioner.
A subset of eight participants chose not to disclose which of
these two diagnostic categories pertained to them. Recruitment
occurred via outpatient hospital clinics (N = 6) and online
research websites (as above).
Replication and Test-Retest Samples
Two additional samples were recruited via the undergraduate
student pool at the University of Western Australia. Applying
the same exclusion criteria as used for the original sample, 659
students (438 female, 221 male, M age = 20.92 years, SD =
5.58, range 16–71) were used to test the replicability of the
factor structure. A further 96 students (68 female, 27 male, 1
“other”;M age= 19.82 years, SD= 4.49, range 17–41) completed
the MUSEQ at two time points (6 months apart) to determine
test-retest reliability.
Questionnaires
Demographic and Health Questionnaire
The non-clinical sample (N = 513) completed 13 questions
relating to demographic information (e.g., age, gender, education
level, and marital status). There were also 10 questions
covering lifetime medical history (sleep disorder, epilepsy,
traumatic head injury, neurodegenerative disease), mental health
history (including schizophrenia spectrum disorder and bipolar
disorder), and sensory-related conditions or experiences (eye
problems/disease not including glasses/contact prescriptions,
ear/nose/throat problems, and synaesthesia). The year of
diagnosis was requested for any questions positively endorsed
(where applicable).
Cardiff Anomalous Perception Scale (CAPS)
The CAPS (Bell et al., 2006) is a 32-item self-report measure that
assesses a range of perceptual anomalies (e.g., sensory intensity,
sensory flooding, and hallucinations) on a dichotomous “Yes”
or “No” scale. If items are positively endorsed, participants
are required to rate the distress (“Not at all distressing” to
“Very distressing”), intrusiveness (“Not at all distracting” to
“Completely intrusive”), and frequency (“Happens hardly at all”
to “Happens all the time”) associated with that experience on
a 1–5 Likert scale. Total scores range from 0 to 32 (for the
dichotomous responses) and subscale scores range from 0 to 160
(for the five-point responses).
Launay Slade Hallucination Scale-Modified-II
(LSHS-M-II)
The LSHS-M-II (Larøi and Van der Linden, 2005) is a 16-item
self-report scale assessing hallucination proneness. This study
used Larøi and Van der Linden’s (2005) adaptation of the scale,
but excluded the follow-up questions. Items are rated on a five-
point Likert scale (0: “Certainly does not apply to me” to 4:
“Certainly applies to me”). Potential scores range from 0 to 60.
Oxford-Liverpool Inventory of Feelings and
Experiences—Short Version (O-LIFE-S)
The O-LIFE-S (Mason et al., 2005) is a 43-item self-report
measure of schizotypal traits. We utilized three subscales:
unusual experiences (UE; 12 items), cognitive disorganization
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(CD; 11 items), and introvertive anhedonia (IA; 10 items). Items
are rated on a dichotomous “Yes” or “No” scale, and potential
scores range from zero to the total number of items in each
subscale.
Scale Development
Item Creation
The objective of the item creation stage was to identify a range
of questions to assess USE according to a continuum structure.
This included items ranging from the most frequent phenomena
(likely to be strongly endorsed) through to “borderland”-like
perceptual experiences, which are experienced as external and
non-self (i.e., akin to clinical phenomena). This continuum was
informed by theoretical work which describes the qualitative
ranges in consciousness and subjectivity that occur in schizotypy,
the prodrome phase of psychosis, and in some organic, medical,
or affective states (Meehl, 1962; Jansson, 2014).
An extensive review was conducted of scales and interviews
that assess hallucination proneness, delusional ideation,
psychosis proneness, schizotypy, perceptual anomalies, and
hallucinations in different clinical groups (see Table 1). Items
were selected in six modalities (auditory, visual, olfactory,
gustatory, bodily sensations, and sensed presence). This review
resulted in a list of 82 items, which were used as a foundation to
create the new scale items.
With the exception of sensed presence, items in each modality
were created to encompass a range of experiences corresponding
with the following general continuum structure: item 1 = broad
subclinical sensory experiences (e.g., senses playing tricks), item
2 = changes in perceptual intensity, item 3 = internal events
become externalized, item 4 = misperceptions, and item 5 (and
above) = hallucinations (having a non-self origin). Consultation
was sought with an expert in the field throughout the scale
development process to confirm item suitability.
Item Selection
A brief exploratory factor analysis was initially conducted
on each subscale separately (one-factor) to aid with item
selection analysis. Following Osborne and Costello’s (2009)
guidelines, item analysis involved checking items had appropriate
communalities (>0.40) and strong factor loadings (>0.50) within
their respective subscale. Only one bodily sensation item, which
related to feeling vibration on one’s body with no apparent
stimulus, was removed due to a low communality and weak
factor loading. All other items had adequate communalities,
and medium to strong (0.40–0.79) factor loadings within their
respective subscales. The items were piloted with participants
from the general population (N = 8) who provided feedback on
their relevance, phrasing, and comprehensibility.
The final scale comprised 43 questions organized across six
modality subscales: auditory (7 items), visual (8 items), olfactory
(8 items), gustatory (8 items), bodily sensations (8 items), and
sensed presence (4 items) (see Table 2). Items are rated on
a five-point Likert scale that targets the frequency of USE,
specifically adapted for a non-clinical population (0 = Never
[Never Happened]; 1= Hardly Ever [Once or twice in my life]; 2
= Rarely [Once or twice a year]; 3 = Occasionally [A few times a
year]; 4= Frequently [At least monthly]. TheMUSEQ is available
online (see Supplementary Table 4)
Procedure
Participants anonymously completed the self-report
questionnaires on Qualtrics software accessed via a secure
internet hyperlink, or via hard copy administration. The non-
clinical sample (N = 513) completed the MUSEQ, O-LIFE-S,
LSHS-M-II, and CAPS, whereas the clinical sample (N = 32),
replication sample (N = 659), and test-retest sample (N =
96) completed the MUSEQ only. This study and its protocols
were approved by the Human Research Ethics Committee of
the University of Western Australia. All participants provided
written informed consent prior to their participation.
Statistical Analyses
A series of confirmatory factor analyses were performed using
MPlus 7 (Muthén andMuthén, 1998-2012) in the original sample
(N = 513) in order to assess the factor structure of the new
scale. Due to the non-normal and ordinal nature of the data,
analyses were based on polychoric correlations, and a weighted
least squares means and variance adjusted (WLSMV) estimation
was used (Brown, 2015). For the purposes of factor identification,
all latent variable variances in the model were constrained to 1,
except the second-order model. The second-order model first-
order factors were scaled by constraining a loading from each to
1. Model comparisons were facilitated by testing a series of four
progressively more complex models that have been frequently
used in studies examining the structure of hierarchical constructs
(e.g., Reininghaus et al., 2013; Caspi et al., 2014; Laceulle et al.,
2015):
(i) One-factor model: Tested the hypothesis that all items are
influenced by a general factor and are unidimensional (see
Figure 1Model A).
(ii) Second-order (higher-order) model: Tested the hypothesis
that the covariance between the modality-specific latent
factors is explained by a higher-order general latent factor.
In this model, there is no direct relationship between the
general factor and individual items; rather, the relationship
is indirectly mediated by the modality-specific latent factors
(see Figure 1Model B).
(iii) Bifactor model: Tested the hypothesis that all items load
onto both a general factor and one of the six modality-
specific factors (see Figure 1 Model C). For example, all
auditory items load onto the general factor and the auditory
latent factor, but no other modality-specific factor. This
model specifies a general factor that may reflect what
is common between the items, while also being able to
simultaneously test the unique variance associated with each
modality factor. Thus, the model allows both the general
factor and specific modality factors to have direct influence
on the items, but unlike the second-ordermodel, the specific
modality factors do not mediate the influence of the general
factor.
(iv) Correlated-factors (six-factor) model: Tested the hypothesis
that each modality forms a latent factor, with each factor
influencing a subset of USE in the respective modality (see
Frontiers in Psychology | www.frontiersin.org 5 August 2017 | Volume 8 | Article 1363
Mitchell et al. MUSEQ: Measuring Unusual Sensory Experiences
TABLE 1 | Scales and assessment measures reviewed during development of the MUSEQ.
Self-report scales Clinical interview schedules/Clinician rated assessment
Cardiff Anomalous Perception
Scale
Bell et al., 2006
Community Assessment of
Psychic Experiences
Stefanis et al., 2002
Launay Slade Hallucination
Scale
Launay and Slade, 1981
Revised Hallucination Scale
Morrison et al., 2000
Launay Slade Hallucination
Scale-Modified
Larøi et al., 2004
Launay Slade Hallucination
Scale-Modified-II
Larøi and Van der Linden, 2005
Magical Ideation Scale
Eckbald and Chapman, 1983
Oxford-Liverpool Inventory of
Feelings and Experiences
Mason et al., 1995, 2005
Perceptual Abberation Scale
Chapman et al., 1978
Peters et al. Delusions Inventory
Peters et al., 1999
Schizotypal Personality Questionnaire-Brief
Raine and Benishay, 1995
Self-Rated Visual Hallucination Questionnaire
for Parkinson’s Disease
Barnes and David, 2001
Columbia University Scale for
Psychopathology in Alzheimer’s Disease
Devanand et al., 1992
Examination of Anomalous
Self-Experience
Parnas et al., 2005
Geriatric Mental State Schedule
Copeland et al., 1976
Institute of Psychiatry Visual
Hallucinations Interview
Santhouse et al., 2000
Mental Health Research Institute Unusual
Perceptions Schedule
Copolov and Carter, 1995
Neuropsychiatric Inventory
Cummings et al., 1994
North-East Visual Hallucinations Interview
Mosimann et al., 2008
Olfactory Hallucinations
Phenomenological Survey
Stevenson et al., 2011
Parkinson’s Psychosis Questionnaire
Brandstaedter et al., 2005)
Present State Examination
Wing et al., 1974
Psychotic Symptom Rating Scales
Haddock et al., 1999
Queens Square Visual Hallucination
Inventory
Williams et al., 2008
Scale for Olfactory Hallucinations
Kwapil et al., 1996
Scale for the Assessment of Positive
Symptoms
Andreasen, 1984
Scale for the Assessment of Positive
Symptoms of Parkinson’s Disease
Voss et al., 2013
Schedules for Clinical Assessment in
Neuropsychiatry
Wing et al., 1990
Semi-Structured Interview About
Visions in Psychiatric Patients
Gauntlett-Gilbert and Kuipers, 2005
Semi-Structured Interview on
Complex Visual Hallucinations for
Charles Bonnet Syndrome
Teunisse et al., 1996
Structured Interview for Assessing
Perceptual Anomalies
Bunney et al., 1999
University of Miami Parkinson’s
Disease Hallucination Questionnaire
Papapetropoulos et al., 2008
Figure 1 Model D). This model assumes that the latent
modality factors may be correlated.
These four models were re-tested in the replication sample.
Acceptable model fit was determined using the following
criteria: a relative chi-square statistic<3, root mean square error
of approximation (RMSEA) values <0.08 (good absolute close-
fit <0.05), and comparative fit index (CFI) and Tucker-Lewis
Index (TLI) values >0.90 (good incremental close-fit >0.95)
(Schweizer, 2010). Model comparisons were based on the degree
of practical improvement in the models, as determined by a TLI
difference of 0.10 or greater (Gignac, 2016). The use of a bifactor
model also provided the opportunity to calculate omega subscale
(ωs) and omega hierarchical (ωh) coefficients. The ωs measures
the degree to which the subscales are reliable and interpretable
after controlling for the general factor, while the (ωh) represents
the degree to which the general factor can be interpreted as
reflective of a single common construct while controlling for
the modality factors (Zinbarg et al., 2005; Reise et al., 2013).
There are currently no specific guidelines for interpreting ωs and
ωh coefficients, but Gignac and Kretzschmar (2017) proposed
relative values of<0.20 (relatively small), 0.20–0.30 (typical), and
>0.30 (relatively large) for ωs based on a quantitative survey of
the published literature.
Internal consistency reliability was estimated for each of
the six modality subscales and calculated using the Cronbach’s
α coefficient. Test-retest reliability was determined using a
Pearson’s correlation between MUSEQ scores at two time points
(6 months apart). Convergent and discriminant validity was
assessed by correlating the MUSEQ total and subscale scores
with the LSHS-M-II, CAPS, and O-LIFE-S subscales using
Pearson’s r. The ability of the scale to discriminate between
non-clinical and clinical groups was measured by comparing
mean differences (t-tests) on the total and subscale MUSEQ
scores between the non-clinical sample and clinical sample.
Incremental validity was assessed using t-tests on the data of
participants with and without a history of sleep disorder, eye
problems/disease, and synaesthesia. These three variables were
selected due to sufficient sample size compared to other health
variables recorded during the study. These comparisons allow us
to demonstrate the usefulness of assessing modalities separately,
rather than measuring USE as a unidimensional construct (i.e.,
total score). Given the non-normality of the data, correlation and
mean difference analyses used bootstrapping (1,000 samples) to
estimate the p-values and 95% confidence intervals. Descriptive
and inferential analyses were performed using SPSS Statistics
Version 22.
RESULTS
Factor Structure
One-Factor Model: Is a Unidimensional Model
Suitable?
As can be seen in Table 3, the one-factor model
(Figure 1Model A) was associated with unacceptable levels
of absolute (RMSEA) and incremental close-fit (CFI and TLI).
Factor loadings are shown in Table 4. These results indicated
that a unidimensional general factor was not appropriate in
explaining the relationship between the MUSEQ items.
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TABLE 2 | Final MUSEQ items.
There have been times when...
AUDITORY
A1. My ears have played tricks on me
A2. Sounds were louder than they normally would be
A3. I thought of a song and could almost hear it with distinct clarity
A4. I was in a crowd or with other people and heard my name being called, only to find that I was mistaken
A5. I have heard my phone ring then found that it wasn’t ringing at all
A6. I could hear sounds, music, or noises that other people could not hear
A7. I have heard a person’s voice and then found that no-one was there
VISUAL
V1. My eyes have played tricks on me
V2. I found that lights or colors seem brighter or more intense than they normally would be
V3. I thought of people, objects, or landscapes, and could almost see their image in front of my eyes
V4. I have looked at a patterned object (e.g., wallpaper, curtains, tiled floor) and a figure or face has emerged
V5. I have seen lights, flashes, or other shapes that other people could not see
V6. I looked at an object and it transformed itself before my eyes into something else
V7. I saw a brief image of an object, animal, or person pass me by in my peripheral vision, but when I looked there was nothing there
V8. I saw people, faces, or animals, and then found that nothing was there
OLFACTORY
O1. My nose (sense of smell) has played tricks on me
O2. I thought that everyday smells were unusually strong
O3. I thought of a smell and I could almost smell it for real
O4. Common smells seemed unusually different
O5. I noticed the smell of smoke, burning, or gas when there was nothing there
O6. I have suddenly been struck by an unpleasant or disgusting smell that no-one else could smell
O7. I have suddenly been struck by a very pleasant smell that no-one else could smell
O8. I have been struck with the smell of odd things which I interpreted as death, colors, or ghosts
GUSTATORY
G1. My sense of taste has played tricks on me
G2. I thought that food or drink tasted stronger than it normally would
G3. I thought of a taste and found that I could taste it in my mouth as if it was real
G4. I ate the same food as another person and thought it tasted off, but the other person did not seem to think so
G5. I have consumed food or drink and it tasted like something completely different
G6. I had nothing in my mouth but I suddenly tasted something very confusing which faded very quickly
G7. I had nothing in my mouth but I suddenly tasted something unpleasant which was really persistent
G8. I had nothing in my mouth but I suddenly tasted something very pleasant which was really persistent
BODILY SENSATIONS
BS1. My body senses have played tricks on me
BS2. I found my skin to be more sensitive to cold, heat, or touch than usual
BS3. I thought of a touch or other sensations on my skin and almost felt it on my skin
BS4. I have experienced the sensation that my body (or part of my body) was different in shape or size
BS5. I could feel burning, tingling, scraping, or heat on my skin, although there was nothing causing it
BS6. I have felt things moving or crawling on or under my skin
BS7. I have experienced the sensation that something was pressing on my skin, or that I was holding an object in my hand, but then found there was nothing there
BS8. I have felt someone or something touching me, but when I turned to look there was nothing there
SENSED PRESENCE
SP1. I felt the presence of someone, even though I could not see them (e.g., behind me, or in another room)
SP2. I have felt an unseen evil presence around me
SP3. I have felt an unseen angelic presence around me
SP4. I have felt the presence of a relative or friend who has passed away
Second-Order Model: Is the Covariance between
Modalities Explained by a Higher-Order General
Factor?
The second-order model (Figure 1 Model B) yielded acceptable
absolute and incremental close-fit. All standardized loadings
were significant (p < 0.001) and positive (see Table 4). Loadings
between the general factor and the modality factors ranged from
0.70–0.91 (all p < 0.001). The TLI difference >0.10 in favor of
Model B vs. Model A suggested practical improvement in model
fit for Model B (compared to Model A) (see Table 3).
Bifactor Model: Can the Variance Be Explained by
both a General Factor and Modality-Specific Factor?
The bifactor model (Figure 1 Model C) yielded acceptable
absolute and incremental close-fit (see Table 3). All items loaded
significantly (p < 0.001, item V3 p = 0.01) onto their respective
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FIGURE 1 | Confirmatory factor analysis models. Model A, One-Factor Model; Model B, Second-Order Model; Model C, Bifactor Model; Model D, Correlated-Factors
Model.
modality factors, with the exception of item V2 on the visual
factor (see Table 5). All items loaded significantly (p < 0.001) on
the general factor, ranging from 0.45 to 0.77. There was practical
improvement in model fit (TLI difference >0.10) from Model A
to C, but not from Model B to C (see Table 3).
In order to determine the strength and importance of the
modality factors in the bifactor model, the ωs coefficients and
ωh coefficient were estimated. Modality subscales were associated
with the following ωs estimates: auditory ωs = 0.26 (typical);
visual ωs = 0.14 (relatively small); olfactory ωs = 0.24 (typical);
gustatory ωs = 0.29 (typical); bodily sensations ωs = 0.21
(typical); and sensed presence ωs = 0.44 (relatively large). The
general factor was found to be associated with a ωh = 0.92. Thus,
the subscales appear to account for a relatively small amount
of unique variance compared to the variance explained by the
general factor.
The Correlated-Factors Model: Six Modality-Specific
Dimensions
As shown in Table 3, the correlated-factors model (Figure 1
Model D) fit the data well and was associated with acceptable
levels of absolute and incremental close-fit. Standardized factor
loadings (see Table 5) were all positive and significant at the p <
0.001 level. The correlations between the sensorymodality factors
ranged from 0.49 to 0.83, with the strongest correlations yielded
between the visual and bodily sensations factors (r = 0.83),
followed by the auditory and visual factors (r = 0.81). The TLI
difference >0.10 in favor of Model D from Model B suggested
practical improvement in model fit for Model D compared to
Model B (see Table 3).
Direct comparisons between Model C (bifactor) and Model
D (correlated-factors) were not possible as they are not nested
models, and the WLSMV estimator does not provide estimations
of alternative comparative fit indices (e.g., Akaike information
criterion or Bayesian information criterion). Both models
appeared to fit the data relatively well, with Model D being
the most parsimonious model. A comparison of the specific
modality factor loadings for Model C and Model D (see Table 5)
found that, generally, loadings were greatly reduced when the
general factor was removed in the bifactor model (e.g., item V1
reduced from 0.78 to 0.26). This suggested that the general factor
accounted for a majority of the variance between USE in different
modalities. However, it is important to note that for some items
the difference was minimal (e.g., item A4Model C= 0.51, Model
D= 0.58 and item SP3 Model C= 0.68, Model D= 0.80), which
suggests that the specific modality factors still account for some
unique variance.
Descriptive Statistics
Given the findings of the factor analyses, the 43-item scale with
six modality factors was conceptualized as the Multi-Modality
Unusual Sensory Experiences Questionnaire (MUSEQ).
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TABLE 3 | Model fit statistics associated with the confirmatory factor analysis
models for the original and replication samples.
Original sample (N = 513) Replication sample (N = 659)
MODEL STATISTICS
Null (Baseline)
χ2 21,842.31 32,253.55
df 903 903
χ2:df 24.19 35.72
RMSEA [90% CI] 0.213 [0.194, 0.231] 0.230 [0.210, 0.249]
CFI 0.000 0.000
TLI 0.000 0.000
A: One-Factor
χ2 3,851.21 4,632.97
df 860 860
χ2:df 4.48 5.39
RMSEA [90% CI] 0.082 [0.080, 0.085] 0.082 [0.079, 0.084]
CFI 0.857 0.880
TLI 0.850 0.874
B: Second-Order
χ2 2,136.61 2,834.77
df 854 854
χ2:df 2.50 3.32
RMSEA [90% CI] 0.054 [0.051, 0.057] 0.059 [0.057, 0.062]
CFI 0.939 0.937
TLI 0.935 0.933
C: Bifactor
χ2 1,978.25 2,621.57
df 817 817
χ2:df 2.42 3.21
RMSEA [90% CI] 0.053 [0.050, 0.056] 0.058 [0.055, 0.060]
CFI 0.945 0.942
TLI 0.939 0.936
D: Correlated-Factors
χ2 1,978.82 2,468.66
df 845 845
χ2:df 2.34 2.92
RMSEA [90% CI] 0.051 [0.048, 0.054] 0.054 [0.052, 0.056]
CFI 0.946 0.948
TLI 0.942 0.945
χ
2, chi-square; χ2:df, degrees of freedom, relative chi-square; RMSEA, root mean
square error of approximation; CI, confidence interval; CFI, Comparative Fit Index; TLI,
Tucker-Lewis Index.
Summing item responses on the 0–4 Likert scale, total scores
can range from 0 to 172, with possible subscale scores as follows:
auditory (0–28), visual (0–32), olfactory (0–32), gustatory (0–32),
bodily sensations (0–32), and sensed presence (0–16). Table 6
presents the descriptive statistics associated with the MUSEQ for
the non-clinical and clinical samples, as well as the LSHS-M-II,
CAPS, and O-LIFE-S for the non-clinical sample.
Reliability
Internal Consistency
The MUSEQ subscales possess good internal consistency with
Cronbach’s alpha coefficients as follows: auditory α= 0.82; visual
TABLE 4 | Standardized factor loadings (WLSMV) for the one-factor and
second-order models in the original sample (N = 513).
Model A (one-factor) Model B (second-order)
Item General A V O G BS SP General
A 0.84
A1 00.63 0.73
A2 0.61 0.71
A3 0.52 0.61
A4 0.50 0.58
A5 0.50 0.59
A6 0.65 0.76
A7 0.68 0.79
V 0.91
V1 0.72 0.79
V2 0.67 0.73
V3 0.65 0.70
V4 0.62 0.67
V5 0.72 0.79
V6 0.71 0.77
V7 0.73 0.79
V8 0.76 0.82
O 0.85
O1 0.67 0.76
O2 0.66 0.74
O3 0.63 0.71
O4 0.73 0.82
O5 0.64 0.72
O6 0.70 0.78
O7 0.74 0.82
O8 0.73 0.82
G 0.83
G1 0.73 0.82
G2 0.70 0.79
G3 0.67 0.76
G4 0.66 0.75
G5 0.72 0.80
G6 0.74 0.83
G7 0.73 0.81
G8 0.79 0.87
BS 0.89
BS1 0.75 0.82
BS2 0.68 0.75
BS3 0.70 0.77
BS4 0.62 0.68
BS5 0.65 0.71
BS6 0.58 0.64
BS7 0.76 0.83
BS8 0.77 0.84
SP 0.70
SP1 0.62 0.85
SP2 0.60 0.81
SP3 0.59 0.80
SP4 0.48 0.65
Factor loadings in bold not significant (p > 0.05). A, Auditory; V, Visual; O, Olfactory; G,
Gustatory; BS, Bodily Sensations; SP, Sensed Presence.
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TABLE 5 | Standardized factor loadings (WLSMV) for the bifactor and correlated-factors models in the original sample (N = 513).
Model C (bifactor) Model D (correlated-factors)
Item General A V O G BS SP A V O G BS SP
A 0.81 0.68 0.66 0.75 0.61
A1 0.61 0.39 0.73
A2 0.61 0.26 0.71
A3 0.53 0.19 0.61
A4 0.46 0.51 0.58
A5 0.48 0.43 0.59
A6 0.64 0.42 0.76
A7 0.67 0.40 0.79
V 0.73 0.70 0.83 0.70
V1 0.72 0.26 0.78
V2 0.69 0.09 0.73
V3 0.66 0.12 0.70
V4 0.61 0.32 0.67
V5 0.72 0.26 0.79
V6 0.69 0.37 0.77
V7 0.70 0.47 0.79
V8 0.73 0.49 0.82
O 0.80 0.73 0.57
O1 0.65 0.39 0.76
O2 0.62 0.49 0.74
O3 0.62 0.23 0.71
O4 0.71 0.35 0.82
O5 0.62 0.34 0.72
O6 0.63 0.58 0.78
O7 0.68 0.54 0.82
O8 0.74 0.16 0.82
G 0.73 0.49
G1 0.66 0.52 0.81
G2 0.61 0.62 0.79
G3 0.67 0.22 0.76
G4 0.63 0.37 0.75
G5 0.66 0.47 0.80
G6 0.69 0.43 0.83
G7 0.67 0.44 0.80
G8 0.73 0.45 0.87
BS 0.62
BS1 0.73 0.33 0.82
BS2 0.66 0.36 0.75
BS3 0.68 0.38 0.77
BS4 0.61 0.30 0.68
BS5 0.61 0.48 0.71
BS6 0.54 0.41 0.64
BS7 0.73 0.39 0.83
BS8 0.77 0.24 0.84
SP
SP1 0.61 0.39 0.85
SP2 0.56 0.63 0.81
SP3 0.54 0.68 0.80
SP4 0.45 0.51 0.65
Factor loadings in bold not significant (p > 0.05). A, Auditory; V, Visual; O, Olfactory; G, Gustatory; BS, Bodily Sensations; SP, Sensed Presence.
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α= 0.88; olfactory α= 0.87; gustatory α= 0.88; bodily sensations
α= 0.88; sensed presence α= 0.77.
Test-Retest
All subscale and total scores showed acceptable test-retest
correlation estimates at the p < 0.001 level: Auditory r = 0.72;
Visual: r = 0.72; Olfactory: r = 0.57; Gustatory: r = 0.56;
Bodily Sensations: r = 0.70; Sensed Presence: r = 0.69; MUSEQ
Total: r = 0.77. In the test-retest sample, the Cronbach’s alpha
coefficients were estimated at: auditory α= 0.86; visual α= 0.91;
olfactory α = 0.92; gustatory α = 0.93; bodily sensations α =
0.88; sensed presence α = 0.85. These results suggested stability
of internal consistency over time.
Validity
Convergent and Divergent Validity
The MUSEQ total score and modality subscale scores
demonstrated good convergent validity through significant
positive correlations with other measures of USE (see Table 7).
Good discriminant validity was also observed via small or non-
significant correlations of the MUSEQ total and subscale scores
with O-LIFE-S subscales that relate to aspects of schizotypy that
are not USE (i.e., CD and IA).
Non-clinical vs. Clinical Group
Table 6 shows the descriptive statistics of the clinical sample. The
clinical sample had significantly higher MUSEQ total scores than
the non-clinical sample (t[543]= 5.25, p<0.001, Cohen’s d [95%
CI]= 0.96 [0.59, 1.32]). The clinical sample also had significantly
higher mean scores on every modality subscale compared to
the non-clinical sample, with moderate to strong effect sizes
(auditory: t[543]= 5.63, p<0.001, d [95%CI]= 1.02 [0.66, 1.39];
visual: t[543]= 4.46, p < 0.001, d [95% CI] = 0.81 [0.45, 1.17];
olfactory: t[543]= 3.57, p< 0.001, d [95% CI]= 0.65 [0.29, 1.01];
gustatory: t[543]= 2.69, p< 0.05, d [95% CI]= 0.49 [0.13, 0.85];
bodily sensations: t[543] = 4.08, p < 0.01, d [95% CI] = 0.74
[0.38, 1.10]; and sensed presence: t[543]= 6.14, p< 0.001, d [95%
CI]= 1.12 [0.75, 1.48]).
Incremental Validity
Participants with sleep disorder reported: sleep apnoea (n
= 18), insomnia (n = 18), night terrors (n = 2), sleep
paralysis disorder (n = 1), and unspecified (n = 14). Those
with a history of eye problems/disease (other than requiring
glasses or contacts) reported the following: cataracts (n =
2), conjunctivitis (n = 2), blepharitis (n = 2), astigmatism
(n = 3), floaters (n = 4), intraocular pressure (n = 2),
macular degeneration (n = 2), amblyopia (n = 2), and
other (e.g., cornea transplant, vitreous detachment, optic
neuritis; n = 28). Thirty-two participants reported experiencing
synaesthesia.
Table 8 shows the results of the t-tests between these groups
and participants without a history of these variables. Participants
who reported a history of sleep disorder scored significantly
higher on the olfactory and gustatory subscales compared to
those who did not, but their scores on other subscales and total
score did not significantly differ. Individuals with a history of
eye problems/disease showed significant elevations on the visual
and sensed presence subscales, with non-significant differences
on other modalities or total scores. The synaesthesia group
scored significantly higher on all modality subscales andMUSEQ
total scores compared to those who did not report experiencing
synaesthesia. The ability for the MUSEQ subscales to yield group
differences on different modality subscales supports its novelty
in contrast to existing scales, which are designed to yield a
single overall score (i.e., equivalent to the MUSEQ total score).
The MUSEQ therefore appears to possess good incremental
validity.
TABLE 6 | Non-clinical and clinical descriptive statistics for the MUSEQ and validation questionnaires.
Scale MUSEQ LSHS-M-II
(N = 500)
CAPS
(N = 498)
O-LIFE-S
(N = 503)
Total A V O G BS SP Total Total D I F UE CD IA
NON-CLINICAL (N = 513)
M (SD) 50.50
(29.94)
12.35
(6.14)
10.00
(7.21)
7.03
(6.17)
6.64
(5.97)
10.61
(7.52)
3.87
(3.44)
21.48
(12.61)
5.51
(5.31)
12.54
(14.71)
13.59
(15.77)
11.69
(13.86)
3.76
(2.74)
4.95
(3.18)
2.73
(2.17)
Median 47 12 9 6 5 10 3 20.50 4 8 8 7 3 5 2
Mode 28 14 5 0 0 0 0 13 0 0 0 0 2 3 2
Min - Max 0–151 0–28 0–32 0–30 0–31 0–32 0–16 0–56 0–31 0–108 0–108 0–98 0–12 0–11 0–9
CLINICAL (N = 32)
M (SD) 79.38
(34.28)
18.63
(5.90)
15.91
(7.99)
11.16
(8.71)
9.63
(7.80)
16.28
(9.17)
7.78
(4.34)
– – – – – – – –
Median 80 19 17 9 8 17 8 – – – – – – – –
Mode 80 25 10 4 8 17 8 – – – – – – – –
Min - Max 15–
143
5–28 3–32 0–30 0–26 0–32 0–16 – – – – – – – –
MUSEQ, Multi-Modality Unusual Sensory Experiences Questionnaire; A, Auditory; V, Visual; O, Olfactory; G, Gustatory; BS, Bodily Sensations; SP, Sensed Presence; LSHS-M-II,
Launay Slade Hallucination Scale-Modified-II; CAPS, Cardiff Anomalous Perception Scale; D, Distress; I, Intrusiveness; F, Frequency; O-LIFE-S, Oxford-Liverpool Inventory of Feelings
and Experiences-Short Version; UE, Unusual Experiences; CD, Cognitive Disorganization; IA, Introvertive Anhedonia.
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TABLE 7 | Bootstrapped pearson correlations between MUSEQ scores and the LSHS-M-II, CAPS, and O-LIFE-S.
MUSEQ (N = 513)
A V O G BS SP Total
LSHS-M-II (N = 500) 0.65** 0.71** 0.55** 0.51** 0.66** 0.60** 0.75**
CAPS (N = 498) 0.54** 0.61** 0.56** 0.51** 0.66** 0.50** 0.69**
O-LIFE (N = 503)
UE 0.54** 0.60** 0.55** 0.48** 0.61** 0.63** 0.67**
CD 0.44** 0.36** 0.28** 0.36** 0.37** 0.22** 0.43**
IA 0.10* 0.08ns 0.02 ns 0.08 ns 0.05 ns 0.04 ns 0.08 ns
MUSEQ: Multi-Modality Unusual Sensory Experiences Questionnaire, Multimodal Unusual Sensory Experiences Questionnaire; LSHS-M-II, Launay Slade Hallucination Scale-Modified-II;
CAPS, Cardiff Anomalous Perception Scale; O-LIFE-S, Oxford-Liverpool Inventory of Feelings and Experiences-Short Version; UE, Unusual Experiences; CD, Cognitive Disorganization;
IA, Introvertive Anhedonia.
**p < 0.01; *p < 0.05; ns, not significant.
TABLE 8 | Mean Differences on MUSEQ subscales and total scores in participants with and without a history of sleep disorder, eye problems/disease, and synaesthesia.
Auditory Visual Olfactory Gustatory Bodily sensations Sensed presence MUSEQ Total
SLEEP DISORDER
Yes (N = 53) M (SD) 12.19 (6.36) 11.23 (6.50) 9.58 (7.16) 8.47 (6.92) 12.08 (7.52) 4.26 (3.77) 57.81 (31.56)
No (N = 457) M (SD) 12.35 (6.13) 9.82 (7.28) 6.73 (6.0) 6.43 (5.83) 10.45 (7.52) 3.82 (3.41) 49.60 (29.76)
t-value t(508) = 0.18 t(508) = 1.35 t(508) = 3.21** t(508) = 2.36* t(508) = 1.49 t(508) =.90 t(508) = 1.89
Cohen’s d [95% CI] 0.03 [−0.31, 0.26] 0.20 [−0.09, 0.48] 0.47 [0.18, 0.75] 0.34 [0.06, 0.63] 0.22 [−0.07, 0.50] 0.13 [−0.16, 0.41] 0.27 [−0.01, 0.56]
EYE PROBLEMS/DISEASE
Yes (N = 47) M (SD) 13.57 (5.10) 12.34 (7.39) 8.45 (6.48) 6.45 (6.21) 11.38 (6.81) 5.19 (4.11) 57.38 (28.12)
No (N = 466) M (SD) 12.23 (6.22) 9.77 (7.16) 6.88 (6.12) 6.66 (5.95) 10.53 (7.59) 3.73 (3.34) 49.80 (30.06)
t-value t(511) = 1.44 t(511) = 2.34* t(511) = 1.66 t(511) = 0.23 t(511) = 0.74 t(511) = 2.79** t(511) = 1.66
Cohen’s d [95% CI] 0.22 [−0.08, 0.52] 0.36 [0.06, 0.66] 0.26 [−0.05, 0.56] 0.04 [−0.34, 0.26] 0.11 [−0.19, 0.41] 0.43 [0.13, 0.73] 0.25 [−0.05, 0.55]
SYNAESTHESIA
Yes (N = 32) M (SD) 15.13 (6.04) 17.13 (7.58) 11.25 (7.40) 9.97 (6.66) 17.0 (7.91) 5.03 (3.22) 75.50 (31.98)
No (N = 481) M (SD) 12.17 (6.10) 9.53 (6.94) 6.75 (5.98) 6.42 (5.86) 10.19 (7.31) 3.79 (3.44) 48.84 (29.08)
t-value t(511) = 2.66** t(511) = 5.96** t(511) = 4.06** t(511) = 3.29** t(511) = 5.08** t(511) = 1.99* t(511) = 4.99**
Cohen’s d [95% CI] 0.49 [0.13, 0.84] 1.09 [0.72, 1.45] 0.74 [0.38, 1.10] 0.60 [0.24, 0.96] 0.93 [0.56, 1.29] 0.36 [0.00, 0.72] 0.91 [0.55, 1.27]
Significant group differences highlighted in bold; **p < 0.01; * p < 0.05; 95% CI = 95% confidence intervals.
Replication Sample
Descriptive statistics for the replication sample yielded similar
results to the initial sample (see Supplementary Table 1). The
four confirmatory factor analysis models (Figure 1) were retested
in the replication sample. As can be seen in Table 3, the pattern
of model absolute and incremental close-fit fit indices yielded by
the analyses were identical to the first study. Specifically, Models
B to D yielded acceptable model fit, while Model A showed
poor model fit. The correlated-factors model (Model D) showed
a practical improvement in fit compared to the second-order
model (Model B), but not from the bifactor model (Model C).
Models B and C did not differ at the practical level (TLI difference
<0.10) of improvement in model fit. Again, Models C and D fit
the data well, but Model D was the most parsimonious model.
Supplementary Tables 2, 3 show the factor loadings of the four
models. Loadings in all four models were significant at the p
< 0.001 level, with BS1 and O8 in Model C significant at p <
0.05. In Model D, the correlations between the sensory modality
factors ranged from 0.56 to 0.86, with the strongest correlations
yielded between the auditory and visual factors (r = 0.86), and
the olfactory and gustatory factors (r = 0.86).
The omega coefficients were again estimated for Model
C. Modality subscales were associated with the following ωs
estimates: auditory ωs = 0.23 (typical); visual ωs = 0.19
(relatively small); olfactory ωs = 0.18 (relatively small); gustatory
ωs = 0.22 (typical); bodily sensations ωs = 0.15 (relatively
small); and sensed presence ωs = 0.43 (relatively large). The
ωh coefficient was 0.93, confirming that in comparison to the
modality subscales, the general factor again accounted for most
of the reliable variance in the MUSEQ items.
DISCUSSION
The current study aimed to develop a reliable and valid
scale that separately assesses USE in six different modalities
(auditory, visual, olfactory, gustatory, bodily sensations, and
sensed presence). Furthermore, it aimed to evaluate the factorial
structure of these experiences and explore whether USE in
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different modalities could be measured separately in addition to
loading onto a general factor. The development of the MUSEQ
was theory-driven, and it was hypothesized that the items and
modalities would be strongly related (i.e., presence of a general
factor), but still uniquely accounting for some unique variance.
Confirmatory factor analyses were used to assess the
psychometric quality of the MUSEQ and explore whether USE
in different modalities were statistically separable. Four different
models were tested: a one-factor model, second-order model,
bifactor model, and correlated-factors model. In both the original
sample and replication sample, the correlated-factors model
and bifactor model showed similar results and yielded the best
model fit. The second-order model also fit the data relatively
well, but was significantly poorer than the correlated-factors
model (but not the bifactor model). The one-factor model fitted
the data poorly, suggesting that capturing all of the USE in
the MUSEQ under one construct (i.e., a general factor) was
not appropriate. All modality factors were positively correlated,
which is consistent with previous findings (Launay and Slade,
1981; Morrison et al., 2000; Larøi and Van der Linden, 2005; Bell
et al., 2006; Lewandowski et al., 2009; Preti et al., 2014).
All models except the unidimensional model fit well in
absolute terms and yielded similar fit indices. This was expected
given that the correlated-factors, second-order, and bifactor
models frequently yield overlapping fit indices despite their
specification of different relationships between the items (see
Morgan et al., 2015). Morgan et al. (2015) suggest that
approximate fit indices are useful, but that conceptual and
substantive grounds must be used in determining which model
most appropriately fits the data. In the current study, the bifactor
model may be the preferred model compared to the correlated
factors model, as the latter does not include a general factor and
attributes all the variance to the modality factors. The presence
of a general factor, in addition to specific modality factors, is
more congruent with the current literature on USE. For example,
theoretical models of visual and auditory hallucinations propose
a role for both specific sensory activation and general cognitive
mechanisms (see Collerton et al., 2005; Barnes and Boubert, 2008;
Waters et al., 2012; Shine et al., 2014; Linszen et al., 2016).
Modality Subscales and Group Differences
Relating to this latter point is the issue of whether the
modality factors are viable as subscales, as the presence of
multidimensionality does not necessarily warrant the creation
of subscores (Reise, 2012). The omega subscale coefficients (ωs)
obtained from the bifactor model can be considered useful
indicators of a factor’s unique strength, independent from the
general factor, and can also help determine the plausibility of
subscales. In the current study, the ωs values obtained in both
the original sample and replication sample were relatively low
to typical in range (Gignac and Kretzschmar, 2017), but do
overlap with coefficients yielded by other psychological measures
with strong validity (see Hull et al., 2010; Tiffin and Rolling,
2012; Dombrowski et al., 2015). Despite the dominance of a
general factor and low to typical ωs values, we argue that
from a theoretical and conceptual point of view, the modality
subscales in theMUSEQ still serve a unique function, as indicated
by theoretically meaningful group differences yielded on the
subscales.
For example, the current results showed individual differences
in the profile of USE supporting the notion of the independence
of modality factors. The community subgroups reporting the
presence of eye disease, sleep disorder, and synaesthesia, each
yielded a unique symptom profile. Those with eye problems
or disease scored significantly higher on the visual and sensed
presence subscales (and not on the other subscales), consistent
with visuoperceptual deficits in this group (Schultz and Melzack,
1991; Scott et al., 2001; Collerton et al., 2005; Schwartzman
et al., 2008; Vukicevic and Fitzmaurice, 2008), and findings
of frequent positive correlations between visual experiences
and sensed presence phenomena (Cheyne and Girard, 2007;
Fénelon et al., 2011). The group with sleep disorder scored
higher on the olfactory and gustatory subscales, which is
in line with the reported side effects of sleep medications
such as zopiclone (Ohayon, 2000). Finally, individuals with
synaesthesia scored significantly higher on all modality subscales
(especially visual) consistent with a blurring of sensory function
(Baron-Cohen and Harrison, 1997) with a predominance
of visual experiences (Novich et al., 2011; Niccolai et al.,
2012).
It is important to note that significant differences in subscale
scores, but not in the total score, suggests that simply calculating a
total score (as is the case with currentmeasures of USE) would fail
to identify these individual differences. Thus, modality subscale
scores serve a unique purpose by unmasking the presence and
frequency of these experiences. The ability to measure USE in
this way may be of great value in future research examining
individual and group differences regarding modalities. Taking
all of our findings into consideration, our hypothesis that USE
may form one large constellation with a common core, but with
the different modalities accounting for some unique variance, is
supported.
What Does the General Factor Represent?
It is also important to acknowledge the dominant general
factor in our model. This general factor may represent what
is commonly referred to as “hallucination proneness,” which
may comprise a range of factors found in individuals with
higher levels of USE (e.g., schizotypal traits, sensory disturbances,
cognitive difficulties, low mood, and other sociodemographic
variables). It could also potentially reflect an accumulation of
vulnerability risk factors, based on research suggesting that the
presence of hallucinations in one modality increases the risk of
hallucinations and USE in other modalities (e.g., Lim et al., 2016;
Clark et al., 2017). However, further investigation is required
to determine what specifically accounts for the shared variance
between modalities.
Psychometric Properties of the MUSEQ
Regarding the MUSEQ more generally, results indicated good
internal reliability and acceptable test-retest reliability. The
test-retest results may be conservative, given that such analyses
assumes a person’s true score remains unchanged (Vaz et al.,
2013). Participants may have experienced additional experiences
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on the MUSEQ in the time between measurements. Both
MUSEQ total and subscale scores yielded significant positive
correlations with other measures of USE indicating good
convergent validity. Furthermore, weak and non-significant
correlations with the CD and IA subscales of the O-LIFE-S were
expected, and indicate good discriminant validity. Overall, these
results indicate that theMUSEQ appears to be a reliable and valid
instrument.
The MUSEQ also demonstrated good ability to discriminate
between clinical and non-clinical groups. The clinical sample
had significantly higher MUSEQ scores (all modalities and total)
than the non-clinical sample, but with a degree of overlap in the
frequency distributions. This finding supports the notion of a
psychosis continuum (Johns and VanOs, 2001), and suggests that
the MUSEQ may have some applicability in clinical populations.
It is important to acknowledge that the subjective experience
appears to differ in a qualitative sense between clinical and non-
clinical samples (Stanghellini et al., 2012). Given the subjective
nature of USE, however, this limitation seems applicable to all
individuals, regardless of their level of pathology.
Sensory Modality Findings
Other results obtained from theMUSEQ yielded some interesting
findings. At the modality level, auditory and visual experiences
were found to be the most common, followed by bodily
sensations. Unusual auditory experiences were slightly more
common than visual experiences. This outcome appears to
contrast with reports that visual experiences may be more
common than auditory experiences in the general population
(Tien, 1991; Ohayon, 2000; McGrath et al., 2015; Peters
et al., 2016). However, there are key differences between the
current study and previous studies including the constructs
being assessed and methodology. Specifically, the MUSEQ
encompasses a continuum of USE, which contrasts with the
standard screening questions in prevalence studies that are more
reminiscent of clinical experiences (e.g., a single question asking
about hearing sounds/voices, or seeing things that others do not).
Future research may therefore be required to explore meaningful
comparisons of the frequency rates of USE in differentmodalities.
Frequency data indicated that USE resembling “hallucination”
(i.e., items at the end of each modality subscale) occurred on
a monthly to annual basis in approximately 5% (for olfactory),
7% (gustatory), 17% (sensed presence), 27% (visual), and 33%
(auditory and bodily sensations) of the non-clinical sample.
These results are congruent with the lifetime prevalence rates
of USE (i.e., hallucinations) in previous large-scale non-clinical
studies (Tien, 1991; Ohayon, 2000; Nuevo et al., 2010; McGrath
et al., 2015; Peters et al., 2016) and support suggestions that they
do not necessarily indicate the presence of psychosis (Linscott
and Van Os, 2013; Waters et al., 2017).
An additional finding of interest was the relatively high
endorsement of the sensed presence items. Sensed presence
experiences are under-researched, with most investigations
focusing on specific populations such as the bereaved (Dewi
Rees, 1971; Keen et al., 2013; Castelnovo et al., 2015),
temporal lobe epilepsy (Cook and Persinger, 1997), and social
isolation (Suedfeld and Mocellin, 1987). Despite ongoing debate
regarding whether sensed presence experiences are illusionary,
hallucinatory, or delusional in nature (Castelnovo et al., 2015),
the current results add to the body of evidence showing these
TABLE 9 | Comparison of the MUSEQ, CAPS, LSHS-M-II and O-LIFE-S features.
Measure
MUSEQ CAPS LSHS-M-II O-LIFE-S
Focus Unusual Sensory Experiences Perceptual Anomalies Hallucination Proneness Schizotypal Traits
Development
population
Non-Clinical Non-Clinical Non-Clinical and Clinical Non-Clinical
Creation method EFA, CFA PCA PCA, Rasch Model EFA
Items 43 32 16 43a
Modality subscales X 5 5 5
Other symptom
dimensions
5 X(D, I, F) 5 X(UE, CD, IA, IN)
Response scale Likert 0–4 Binary (No, Yes) Subscales: Likert 1–5 Likert 0–4 Binary (No, Yes)
Frequency ratings X 5
(Not specific time measurements)
5 5
USE item modalities
(Number of Items)
A, V, O, G, BS, SP (7, 8, 8, 8, 8, 4) A, V, O, G, BS, SP (9, 6, 4, 3, 6, 1) A, V, O, BS, SP (5, 3, 1, 2, 1) A, V, O, SP (UE) (1, 2, 1, 1)
Proneness or
schizotypy items
5 5 Xb Xb
Other item types 5 Time perception; General sensory
flooding; Difficulty distinguishing
sensations
Hypnagogic/hypnopompic item
targeting three separate
modalities (not multimodal)
5
aOnly the UE, CD, and IA subscales were used in this study (33 items).
bLSHS-M-II, includes intrusive thoughts and vivid daydreaming; O-LIFE-S, includes magical powers, intrusive thoughts, cognitive disorganization, anhedonia, and antisocial behavior.
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types of USE occur in a non-negligible number of people in the
general populations (Braithwaite et al., 2013; Castelnovo et al.,
2015).
Limitations, Strengths, and Future
Directions
The current study possesses some limitations, one being that
the predictive validity of the MUSEQ and its subscales was
not tested (i.e., the ability for the modality subscales to predict
external criterion above and beyond the general factor). The use
of bifactor modeling (Model C in the current study) allows such
investigations. Future studies may investigate the ability for the
MUSEQ subscales to predict theoretically relevant criteria, and
such research is currently being pursued by the authors. It is
worth noting that the current finding of theoretically meaningful
group differences on the MUSEQ subscales does provide some
initial support for assessing USE in different modalities.
Another limitation is that invariance testing between groups
(e.g., age, students/non-students, and different countries) was
not conducted due to insufficient sample size in the required
subgroups. However, previous studies have found no significant
differences in the frequency of experiences between students and
general communities (e.g., Lincoln and Keller, 2008), or between
individuals residing in countries of a similar socioeconomic
standing (McGrath et al., 2015). One exception is religious beliefs,
which are associated with a higher prevalence of hallucinatory
phenomena (Pelletier-Baldelli et al., 2014; Steenhuis et al., 2016).
Although of interest, exploring such factors was outside the scope
of this study. In regard to other invariance factors (e.g., age), only
8.5% of the current sample were older than 50 years of age, and
thus it is unlikely this subsample would have significantly affected
the results.
While our focus was on the six most common modalities,
we are aware of other, less common, modalities such as
proprioceptive, kinesthetic, vestibular, temporal, sexual, pain,
and cenesthetic (Blom, 2013). There also exists multimodal USE,
in which the experience occurs in more than one modality
simultaneously or serially (see Lim et al., 2016). There is no
doubt that investigating such experiences would be of great
value, but this was beyond the scope of the current study.
Future adaptations of the scale may wish to consider these
other modalities and more complex multimodal experiences, or
include sections allowing for qualitative responses about USE
in different modalities. The authors are currently working on
the addition of other dimensions to the scale such as distress,
intrusiveness, and impact, and testing the reliability and validity
of these modifications.
A strength of this study included a novel approach which
explored the underlying structure of USE in the general
population by creating a scale designed to investigate whether
there is any use in separating out modalities at the measurement
level. Another strength was our sample sizes, allowing sufficient
exploration of USE and replication of our results in a
separate sample. The MUSEQ also possesses strengths, including
the ability to discriminate between different groups across
modalities, and the use of a more precise frequency rating scale.
Existing measures of USE calculate a total score and use response
formats that do not tap into the frequency of unusual experiences,
or which target frequency in a non-specific way. The features of
theMUSEQ compared to the LSHS-M-II, and O-LIFE are further
demonstrated in Table 9. It is hoped that the current findings and
the creation of the MUSEQ will aid further investigations of USE
in the general population.
CONCLUSION
In conclusion, the MUSEQ is a reliable and valid scale that
measures USE in six different modalities. Results suggested that
a correlated-factors model and a bifactor model fit the data
similarly well, while a one dimensional model fitted poorly.While
the unique modality factors accounted for less variance than
the general factor, the subscales were able to detect theoretically
meaningful differences in groups of individuals with a history
of eye problems/disease, sleep disorder, and synaesthesia. This
has important implications for the measurement of USE, such
that it allows greater specificity and better characterization
of experiences while moving away from the commonly used,
but poorly defined, construct of “hallucination proneness.”
It also indicates that ignoring experiences in commonly
under-represented modalities may be slowing progress in
understanding such phenomena.
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